CIBC Asset Management Inc - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIBC Asset Management Inc ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2022$32,393
-36.5%
14,333
-10.0%
0.00%
Q3 2022$51,000
-15.0%
15,9210.0%0.00%
Q2 2022$60,000
-32.6%
15,921
-3.4%
0.00%
Q1 2022$89,000
-60.1%
16,4880.0%0.00%
-100.0%
Q4 2021$223,000
-12.9%
16,488
+17.5%
0.00%
-50.0%
Q3 2019$256,000
-48.8%
14,032
-0.2%
0.00%
-33.3%
Q2 2019$500,000
+8.9%
14,059
+3.0%
0.00%0.0%
Q1 2019$459,000
+0.9%
13,656
-1.4%
0.00%0.0%
Q4 2018$455,000
-46.0%
13,850
+0.3%
0.00%
-40.0%
Q3 2018$842,000
+24.0%
13,812
-0.7%
0.01%
+25.0%
Q2 2018$679,000
-52.1%
13,915
+4.4%
0.00%
-55.6%
Q1 2018$1,417,000
+338.7%
13,334
+146.2%
0.01%
+350.0%
Q4 2017$323,000
+19.6%
5,415
-51.8%
0.00%0.0%
Q3 2017$270,000
+33.0%
11,240
+8.4%
0.00%
+100.0%
Q2 2017$203,000
-16.5%
10,3660.0%0.00%
-50.0%
Q1 2017$243,000
+91.3%
10,3660.0%0.00%
+100.0%
Q4 2016$127,00010,3660.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2018
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders